Pharma & Biotech

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The biopharmaceutical firm is...

The year 2026 is shaping up to be a critical period for Vir Biotechnology, with a series of scheduled clinical...

Coherus BioSciences has secured a significant partnership for its clinical development efforts, aligning with Janssen Research & Development, a Johnson...

Akso Health Group has solidified its strategic shift into the healthcare industry with the launch of a major global program...

The recent foray by telehealth company Hims & Hers into the lucrative weight-loss medication sector has hit an early regulatory...

AnaptysBio has confirmed its participation in several upcoming investor conferences, where management will detail a major corporate restructuring. The centerpiece...

Pharmaceutical giant Pfizer is navigating a critical strategic shift, moving decisively away from reliance on its declining COVID-19 business and...

The independent journey of Dynavax Technologies on the public markets is drawing to a definitive close. The biopharmaceutical firm is...

Shares of Viking Therapeutics are trading within a consolidated range as the market anticipates significant corporate news. The biotechnology firm...

The chapter for CureVac as an independent publicly traded company has officially closed. The biotech firm's shares have been removed...